HSBC initiates Mao Geping Cosmetics stock with Buy rating on premium positioning

HSBC initiated coverage on Mao Geping Cosmetics Co (HK:1318) with a Buy rating and a HK$131.70 price target, positioning the company as the only domestic player among China's top premium beauty groups. The bank anticipates significant market outperformance, driven by brand strength and its understanding of local consumer preferences, forecasting a 31% revenue CAGR and a 35% net profit CAGR for 2024-27, with its 2025 net profit estimate 9% above consensus.

Analysis

HSBC has initiated coverage on Mao Geping Cosmetics Co (HK:1318) with a 'Buy' rating and a price target of HK$131.70, signaling strong confidence in the premium beauty brand. The core of the investment thesis rests on the company's unique position as the only domestic player among the top 10 premium beauty groups in China. HSBC highlights a key competitive advantage in the brand's deep understanding of local consumer preferences, specifically tailoring products for Asian aesthetics and skin types. This is expected to drive significant outperformance and market share gains amid consolidation in the premium segment. The growth outlook is exceptionally strong, with HSBC forecasting a revenue CAGR of 31% and a net profit CAGR of 35% between 2024 and 2027. Notably, the bank's 2025 net profit estimate is 9% above consensus, suggesting the market may be underestimating the firm's earnings potential.

Key Decisions for Investors

• Investors should consider the 'Buy' rating and above-consensus profit estimates from HSBC as a signal that the market may be underpricing Mao Geping's growth potential.
• The core investment thesis is the company's unique positioning as the sole domestic brand in China's top-tier premium beauty market; portfolio managers should assess the durability of this competitive advantage against international rivals.
• Monitor quarterly results closely to track whether the firm is achieving the high-growth targets, specifically the forecasted 31% revenue and 35% net profit CAGR, which are critical for validating HSBC's bullish outlook.